RTRicardo Henrique de Oliveira Braga Teixeira

Ricardo Henrique de Oliveira Braga Teixeira

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Ricardo Henrique de Oliveira Braga Teixeira has a total of 32 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    P14.01: Cryobiopsy in the Diagnosis of Lung Allograft Rejection: Brazilian Case Series

    by Carlos E F Belon, Elissa A Okuno, Silvia V Campos, Ascedio J Rodrigues, Evelisse Lima, Paulo R Scordamaglio, Priscila C L B Camargo, Ricardo H O B Teixeira, Rafael M Carraro, Andre N Costa, et al.

  • Open Access

    Brazilian initial experience with lung transplantation due to irreversible lung fibrosis post-COVID-19 in a national reference center: a cohort study

    by Flavio Pola dos Reis, Lucas Matos Fernandes, Luis Gustavo Abdalla, Silvia Vidal Campos, Priscila Cilene Leon Bueno de Camargo, Samuel Lucas dos Santos, Ivana Teixeira de Aguiar, Juliana Patricia Pires, Andre Nathan Costa, Rafael Medeiros Carraro, et al.

    BACKGROUND: Lung transplantation (LTx) has been discussed as an option for treating irreversible lung fibrosis post-coronavirus disease 2019 (COVID-19), in selected cases. OBJECTIVES: To report on the initial experience and management of end-stage lung disease due to COVID-19 at a national center reference in Brazil. DESIGN AND SETTING: Cohort study conducted at a national reference center for lung transplantation. METHODS: Medical charts were reviewed regarding patients'demographics and pre-COVID-19 characteristics, post-LTx due to COVID-19. RESULTS: Between March 2020 and September 2021, there were 33 cases of LTx. During this period, we evaluated 11 cases of severe COVID-19-related acute respiratory distress syndrome (ARDS) that were potentially candidates for LTx. Among these, LTx was only indicated for three patients ( 9.1%). All of these patients were on venovenous extracorporeal membrane oxygenation ( ECMO), and the procedure that they underwent was central venoarterial ECMO. All three patients were still alive after the first 30 postoperative days. However, patient #1 and patient #2 subsequently died due to fungal sepsis on the 47th and 52nd postoperative days, respectively. Patient #3 was discharged on the 30th postoperative day. CONCLUSIONS: LTx is feasible among these complex patients. Survival over the first 30 days was 100%, and this favors surgical feasibility. Nonetheless, these were critically ill patients.


  • Open Access

    Early COVID-19 infection after lung transplantation in a patient with cystic fibrosis

    by Rodrigo Abensur Athanazio, André Nathan Costa, Rafael Medeiros Carraro, Diego Gonzalez, Samia Zahi Rached, Marcos Naoyuki Samano, Ricardo Henrique de Oliveira Braga Teixeira, Silvia Vidal Campos

    Since December 2019, when the initial cases of severe viral pneumonia caused by a new coronavirus were described, health services worldwide have sought to understand the evolution and risk factors related to the severity of coronavirus disease (COVID-19). Elderly individuals have been shown to be the highest risk group. However, other factors, such as male sex; obesity; smoking; and chronic heart, lung, kidney, and liver diseases, are also associated with a poor prognosis. We draw attention to immunosuppressed patients as [...] Since December 2019, when the initial cases of severe viral pneumonia caused by a new coronavirus were described, health services worldwide have sought to understand the evolution and risk factors related to the severity of coronavirus disease (COVID-19). Elderly individuals have been shown to be the highest risk group. However, other factors, such as male sex; obesity; smoking; and chronic heart, lung, kidney, and liver diseases, are also associated with a poor prognosis. We draw attention to immunosuppressed patients as


  • Open Access

    Extracorporeal Membrane Oxygenation and Lung Transplantation: Initial Experience at a Single Brazilian Center

    by Flávio Pola-Dos-Reis, Marcos Naoyuki Samano, Luis Gustavo Abdalla, Guilherme Vieira Soares de Carvalho, Lucas Matos Fernandes, Oswaldo Gomes-Júnior, Rafael Medeiros Carraro, Priscila Cilene Leon Bueno de Camargo, Ricardo Henrique Oliveira Braga Teixeira, José Eduardo Afonso-Júnior, et al.

    To report initial experience from the use of extracorporeal membrane oxygenation (ECMO) in patients who received lung transplantation. Retrospective study of a single tertiary center in the Brazilian state of São Paulo, a national reference in lung transplantation, based on the prospective collection of data from electronic medical records. The period analyzed extended from January 2009 (beginning of the program) until December 2018. A total of 75 lung transplants were performed, with ECMO used in 8 (10.7%) cases. Of the patients, 4 (50%) were female. The mean age was 46.4±14.3 years. The causes of the end-stage lung disease that led to transplantation were pulmonary arterial hypertension in 3 (37.5%) patients, bronchiectasis in 2 (25%) patients, pulmonary fibrosis in 2 (25%) patients, and pulmonary emphysema in 1 (12.5%) patient. In our series, 7 (87.5%) cases were sequential bilateral transplantations. Prioritization was necessary in 4 (50%) patients, and in 1 patient, ECMO was used as a bridge to transplantation. The ECMO route was central in 4 (50%), peripheral venovenous in 2 (25%) and peripheral venoarterial in 2 (25%) patients. The mean length of the intensive care unit (ICU) stay was 14±7.5 days and of the hospital stay was 34.1±34.2 days. The mean ECMO duration was 9.3±6.6 days with a 50% decannulation rate. Three patients were discharged (37.5%). Lung transplantation requires complex treatment, and ECMO has allowed extending the indications for transplantation and provided adjuvant support in the clinical management of these patients.


  • Incidence and Mortality by Cancer in Patients After Lung Transplantation in a Brazilian Institution

    by M. Schettini-Soares, O.G. Júnior, H.F. Costa, L.M. Fernandes, L.G. Abdalla, S.V. Campos, R.H.O.B. Teixeira, M.N. Samano, P.M. Pêgo-Fernandes


  • Open Access

    Psychological criteria for contraindication in lung transplant candidates: a five-year study

    by Elaine Marques Hojaij, Bellkiss Wilma Romano, André Nathan Costa, Jose Eduardo Afonso Junior, Priscila Cilene Leon Bueno de Camargo, Rafael Medeiros Carraro, Silvia Vidal Campos, Marcos Naoyuki Samano, Ricardo Henrique de Oliveira Braga Teixeira

    Lung transplantation presents a wide range of challenges for multidisciplinary teams that manage the care of the recipients. Transplant teams should perform a thorough evaluation of transplant candidates, in order to ensure the best possible post-transplant outcomes. That is especially true for the psychologist, because psychological issues can arise at any point during the perioperative period. The objective of our study was to evaluate the psychological causes of contraindication to waiting list inclusion in a referral program for lung transplantation. We retrospectively analyzed data on psychological issues presented by lung transplant candidates, in order to understand these matters in our population and to reflect upon ways to improve the selection process.


  • Open Access

    Cytokine levels in pleural fluid as markers of acute rejection after lung transplantation

    by Priscila Cilene León Bueno de Camargo, José Eduardo Afonso Jr, Marcos Naoyuki Samano, Milena Marques Pagliarelli Acencio, Leila Antonangelo, Ricardo Henrique de Oliveira Braga Teixeira

    Our objective was to determine the levels of lactate dehydrogenase, IL-6, IL-8, and VEGF, as well as the total and differential cell counts, in the pleural fluid of lung transplant recipients, correlating those levels with the occurrence and severity of rejection. We analyzed pleural fluid samples collected from 18 patients at various time points (up to postoperative day 4). The levels of IL-6, IL-8, and VEGF tended to elevate in parallel with increases in the severity of rejection. Our results suggest that these levels are markers of acute graft rejection in lung transplant recipients.